Effect of gut microbiota on depressive-like behaviors in mice is mediated by the endocannabinoid system

Grégoire Chevalier,Eleni Siopi,Laure Guenin-Macé,Maud Pascal,Thomas Laval,Aline Rifflet,Ivo Gomperts Boneca,Caroline Demangel,Benoit Colsch,Alain Pruvost,Emeline Chu-Van,Aurélie Messager,François Leulier,Gabriel Lepousez,Gérard Eberl,Pierre-Marie Lledo
DOI: https://doi.org/10.1038/s41467-020-19931-2
IF: 16.6
2020-12-01
Nature Communications
Abstract:Abstract Depression is the leading cause of disability worldwide. Recent observations have revealed an association between mood disorders and alterations of the intestinal microbiota. Here, using unpredictable chronic mild stress (UCMS) as a mouse model of depression, we show that UCMS mice display phenotypic alterations, which could be transferred from UCMS donors to naïve recipient mice by fecal microbiota transplantation. The cellular and behavioral alterations observed in recipient mice were accompanied by a decrease in the endocannabinoid (eCB) signaling due to lower peripheral levels of fatty acid precursors of eCB ligands. The adverse effects of UCMS-transferred microbiota were alleviated by selectively enhancing the central eCB or by complementation with a strain of the Lactobacilli genus. Our findings provide a mechanistic scenario for how chronic stress, diet and gut microbiota generate a pathological feed-forward loop that contributes to despair behavior via the central eCB system.
multidisciplinary sciences
What problem does this paper attempt to address?
The problem that this paper attempts to solve is: **How does the gut microbiota affect depressive - like behaviors in mice through the endocannabinoid system (eCB)?** Specifically, the study aims to explore whether changes in the gut microbiota caused by chronic stress can be transmitted to normal mice through fecal microbiota transplantation (FMT), and lead to depressive - like behaviors in these mice and its underlying mechanisms. ### Research Background Depression is the leading cause of disability worldwide, currently affecting more than 300 million people. Despite the high prevalence and economic impact of depression, its pathophysiological mechanisms are still not fully understood. Recent studies have shown that mood disorders are associated with changes in the gut microbiota. However, the specific mechanisms by which the gut microbiota affects brain function and leads to depressive - like behaviors have not been clarified. ### Research Questions 1. **Can the gut microbiota transmit depressive - like behaviors?** - Through the unpredictable chronic mild stress (UCMS) model, the researchers observed that UCMS mice exhibited depressive - like behaviors, and these behaviors could be transmitted to normal mice through fecal microbiota transplantation. 2. **How does the gut microbiota affect the endocannabinoid system?** - The study found that the levels of monoacylglycerol (MAG) and diacylglycerol (DAG) in the serum of UCMS mice and their recipient mice were significantly decreased, especially DAG containing arachidonic acid (AA). This led to a decrease in the level of 2 - arachidonoylglycerol (2 - AG) in the brain, thereby affecting the activity of the endocannabinoid system. 3. **Can restoring the endocannabinoid system improve depressive - like behaviors?** - The researchers increased the level of 2 - AG by inhibiting monoacylglycerol lipase (MAGL) or supplementing AA, and found that these treatments could reverse UCMS - induced depressive - like behaviors and impaired neurogenesis. 4. **Can specific strains (such as Lactobacillus) relieve depressive - like behaviors?** - Supplementing specific Lactobacillus (such as Lactobacillus plantarum WJL) can increase the level of 2 - AG in the brain and neurogenesis, thereby relieving depressive - like behaviors. ### Conclusion This study reveals the important role of the gut microbiota through the endocannabinoid system in depressive - like behaviors caused by chronic stress, and provides new ideas for treating depression by regulating the gut microbiota and the endocannabinoid system.